By the Metrics Surgical Oophorectomy Plus Tamoxifen is the First Adjuvant Treatment Option for Premenopausal Women with Hormone Receptor Positive Breast Cancer

By the Metrics Surgical Oophorectomy Plus Tamoxifen is the First Adjuvant Treatment Option for Premenopausal Women with Hormone Receptor Positive Breast Cancer

NA

Bibliographic Details
Main Author: Richard Love
Format: Article
Language:English
Published: Kaviani Breast Disease Institute 2021-01-01
Series:Archives of Breast Cancer
Subjects:
Adjuvant therapy
Surgical oophorectomy
Tamoxifen
Secondary effects
Key metrics
Online Access:https://www.archbreastcancer.com/index.php/abc/article/view/337
id doaj-d56149a8c57d401cabfa3b199b0f633c
record_format Article
spelling doaj-d56149a8c57d401cabfa3b199b0f633c2021-02-02T21:55:51ZengKaviani Breast Disease InstituteArchives of Breast Cancer2383-04332021-01-0110.32768/abc.2021818-13By the Metrics Surgical Oophorectomy Plus Tamoxifen is the First Adjuvant Treatment Option for Premenopausal Women with Hormone Receptor Positive Breast CancerRichard Love0Department of Computer Science, Marquette University, Milwaukee, WI, USA NA https://www.archbreastcancer.com/index.php/abc/article/view/337Adjuvant therapy Surgical oophorectomyTamoxifenSecondary effects Key metrics
collection DOAJ
language English
format Article
sources DOAJ
author Richard Love
spellingShingle Richard Love
By the Metrics Surgical Oophorectomy Plus Tamoxifen is the First Adjuvant Treatment Option for Premenopausal Women with Hormone Receptor Positive Breast Cancer
Archives of Breast Cancer
Adjuvant therapy
Surgical oophorectomy
Tamoxifen
Secondary effects
Key metrics
author_facet Richard Love
author_sort Richard Love
title By the Metrics Surgical Oophorectomy Plus Tamoxifen is the First Adjuvant Treatment Option for Premenopausal Women with Hormone Receptor Positive Breast Cancer
title_short By the Metrics Surgical Oophorectomy Plus Tamoxifen is the First Adjuvant Treatment Option for Premenopausal Women with Hormone Receptor Positive Breast Cancer
title_full By the Metrics Surgical Oophorectomy Plus Tamoxifen is the First Adjuvant Treatment Option for Premenopausal Women with Hormone Receptor Positive Breast Cancer
title_fullStr By the Metrics Surgical Oophorectomy Plus Tamoxifen is the First Adjuvant Treatment Option for Premenopausal Women with Hormone Receptor Positive Breast Cancer
title_full_unstemmed By the Metrics Surgical Oophorectomy Plus Tamoxifen is the First Adjuvant Treatment Option for Premenopausal Women with Hormone Receptor Positive Breast Cancer
title_sort by the metrics surgical oophorectomy plus tamoxifen is the first adjuvant treatment option for premenopausal women with hormone receptor positive breast cancer
publisher Kaviani Breast Disease Institute
series Archives of Breast Cancer
issn 2383-0433
publishDate 2021-01-01
description NA
topic Adjuvant therapy
Surgical oophorectomy
Tamoxifen
Secondary effects
Key metrics
url https://www.archbreastcancer.com/index.php/abc/article/view/337
work_keys_str_mv AT richardlove bythemetricssurgicaloophorectomyplustamoxifenisthefirstadjuvanttreatmentoptionforpremenopausalwomenwithhormonereceptorpositivebreastcancer
_version_ 1724291324501295104

Similar Items